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Abstract
Background: Initiating parenteral nutrition (PN) within 24 h in critically ill children is inferior to withholding PN
during the first week, as was found in the PEPaNIC study. The aims of this study were to investigate de-
implementation of early initiation of PN at PICUs worldwide, and to identify factors influencing de-implementation.
Methods: A cross-sectional online survey was conducted (May – October 2017), consisting of 41 questions
addressing current PN practices, the degree of de-implementation, and factors affecting de-implementation.
Results: We analysed 81 responses from 39 countries. Of these 81 respondents, 53 (65%) were aware of the
findings of the PEPaNIC study, and 43 (53%) have read the article. In these 43 PICUs, PN was completely withheld
during the first week in 10 PICUs, of which 5 already withheld PN (12%), and 5 de-implemented early initiation of
PN (12%). Partial de-implementation was reported by 17 (40%) and no de-implementation by 16 (37%). Higher de-
implementation rates were observed when the interpreted level of evidence and grade of recommendation of
PEPaNIC was high. Predominant reasons for retaining early initiation of PN were concerns on withholding amino
acids, the safety in undernourished children and neonates, and the long-term consequences. Furthermore, the
respondents were waiting for updated guidelines.
Conclusions: One year after the publication of the PEPaNIC trial, only two-thirds of the respondents was aware of
the study results. Within this group, early initiation of PN was de-implemented completely in 12% of the PICUs,
while 40% asserted partial de-implementation. Increasing the awareness, addressing the intervention-specific
questions and more frequently revising international guidelines might help to accelerate de-implementation of
ineffective, unproven or harmful healthcare.
Keywords: De-implementation, Survey, Questionnaire, Parenteral nutrition, Intensive care units, pediatric, Nutritional
support
Background
Optimal nutrition is considered essential to improve
outcome in the paediatric intensive care unit (PICU) but
large well-designed randomised, controlled trials (RCTs)
with clinically relevant outcome measures are lacking
[1, 2]. The limited evidence leads to a wide variation
in nutritional practices between individual intensivists,
PICUs and countries. This variation includes timing
of and thresholds for the initiation of parenteral
nutrition (PN), as measured by a worldwide survey
with a point-prevalence [3]. According to this survey
completed in 2014, in 20% of the PICUs, PN was
initiated within 24 h after admission, and in 55% of
the PICUs within 48 h [3]. The international guide-
lines at that time were based on small studies with
surrogate outcome measures, observations, and expert
opinion, and could not provide clear recommenda-
tions on the timing of initiating PN in critically ill
children [4, 5]. In 2016, the results of the large,
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: s.verbruggen@erasmusmc.nl
1Department of Paediatrics and Paediatric Surgery, Erasmus MC - Sophia
Children’s Hospital, University Medical Centre Rotterdam, Wytemaweg 80,
3015, CN, Rotterdam, The Netherlands
Full list of author information is available at the end of the article
Puffelen et al. BMC Health Services Research          (2019) 19:379 
https://doi.org/10.1186/s12913-019-4223-x
international, multicentre, RCT ‘PEPaNIC’ (Paediatric
Early versus Late Parenteral Nutrition in Intensive Care)
were published [6]. This RCT showed that administering
PN within 24 h after PICU admission (Early-PN; the
standard therapy) was clinically inferior to withholding
PN during the first week of PICU admission (Late-PN)
[6]. Withholding PN during the first week prevented new
infections, shortened intensive care dependency, the dur-
ation of mechanical ventilation and hospital stay. Based
on the impact of these findings, and the scarcity of evi-
dence for the early use of PN in PICUs, one could expect
that currently, initiation of supplemental PN is delayed
until after the first week of critical illness in the majority
of PICUs.
De-implementation or de-adoption is described as
‘reducing or stopping low-value, ineffective, harmful or
unproven care’. [7–9] However, rational and quantitative
evidence are only part of the driving forces for decision
making and only 49% of the interventions is supported
or contradicted by the available evidence [7, 10]. Little is
known about the factors that influence the extend and
pace of de-implementation [8, 11]. Moreover, currently,
only 10% of the de-implementation research has focused
on paediatric healthcare [9].
In this study, we explored the degree of early de-imple-
mentation of initiating PN in the first week in PICUs and
barriers for de-implementation with a survey among phy-
sicians and dieticians across PICUs worldwide.
Methods
This electronic (LimeSurvey GmbH version 2.06lts)
cross-sectional survey was conducted between May and
October 2017. It consisted of 41 questions and was pro-
vided in English, French and Spanish. The full question-
naire used for this survey can be found as online
supplement to this article (Additional file 1). In brief, the
survey was developed to collect information in different
echelons. The first part collected general information of
the respondents and responding PICUs, the second part
focused on the current practice of PN in the responding
PICU, and the third part investigated the awareness of
the results of the PEPaNIC trial. Subsequently, the re-
spondents who had read the findings of this study prior
to our survey were requested to participate in the final
part of the survey in which they were asked to grade the
quality of evidence of the PEPaNIC trial according to
the Scottish Intercollegiate Guidelines Network (SIGN)
system that was provided in the survey [12]. Finally, they
were asked whether and how the PEPaNIC results has
changed the current practice of initiating PN in their
PICU, and which factors have influenced the degree of
de-implementation in their PICU.
The survey was piloted by independent clinicians in
two different centres (Erasmus MC-Sophia Children’s
Hospital, Rotterdam, the Netherlands and the University
Hospital of Leuven, Belgium) to test the clarity, rele-
vance and clinical sensibility of the questionnaire, and
the questionnaire was adapted accordingly. Data from
this pilot were not included in the final analyses and sur-
vey results. The survey was electronically distributed
among members of the World Federation of Pediatric
Intensive and Critical Care Societies (WFPICCS) by
newsletter and Twitter, and to specific members of the
European Society of Paediatric and Neonatal Intensive
Care (ESPNIC). Reminders were sent three times with
six-week intervals. If more than one questionnaire was
present for a PICU, the answers were weighed by the
inverse of the number of completed questionnaires per
centre in order to process conflicting statements within
one PICU, without disrupting the weight of the answers
per PICU.
Main outcome was the degree of de-implementation
(fidelity), with complete de-implementation defined as
withholding PN until day 8 of PICU admission. Partial
de-implementation was defined as postponed initiation
of PN (but still initiated prior to day 8 in PICU) and/or
decreased amount of PN as compared with nutritional
practices before the results from PEPaNIC, or only ad-
ministering PN during the first week in specific patient
groups. Secondary outcomes were supporting factors
and barriers for de-implementation.
Statistical analysis was performed using IBM SPSS
statistics version 24. All answers were categorical, and
were expressed as numbers and proportions.
Results
Response
Since the survey was distributed via Twitter, ESPNIC
and WFPICCS, with unknown number of PICUs in their
databases, the exact number of invited PICUs is
unknown. A total of 88 completed questionnaires were
received, of which one was removed because the
respondent worked in a Neonatal Intensive Care Unit.
From the remaining 87 questionnaires, the answers of
nine respondents from three centres needed to be
pooled per centre by weighing the answers according to
the number of completed questionnaires per centre. The
3 pooled responses per centre were kept for analyses,
and the individual responses were removed (Fig. 1). Fi-
nally, responses from 81 PICUs in 39 countries on 6
continents were analysed (Fig. 2). Of the respondents,
74% were (paediatric) intensivists, 12% were dieticians or
nutritionists, 6% were paediatricians, 5% were nurses or
nurse practitioners, and 3% were anaesthesiologists.
Of the responding PICUs, 39 (48%) were located in
Europe, 14 (17%) in South America, 12 (15%) in
North America, and 12 (15%) in Asia (Table 1). The
majority of the PICUs had 251–750 paediatric
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Fig. 1 Flowchart of the responses and build-up of the survey. NICU = neonatal intensive care unit; PN = parenteral nutrition
Fig. 2 Participating PICUs: 81 responses from 39 countries (in blue), covering six continents. Created with: https://www.amcharts.com/visited_countries/
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admissions per year (Table 1). All PICU demographics
are displayed in Table 1.
Current PN practices in PICUs
In 50 of the 81 PICUs (62%), a nutritional protocol
regarding PN was present. Most of the protocols were
based on international guidelines (27 of 50, 54%), 8 of 50
(16%) on national guidelines, and 15 of 50 (30%) on the
opinion of the staff. Respondents from 10 of the 81
PICUs (12%) would always start PN if enteral nutrition
(EN) is insufficient, and 4 (5%) would never start PN. In
43 of the 81 PICUs (53%), supplemental PN would be
started if enteral nutrition covered less than 80% of the
target goals, at 20 (25%) of the PICUs if EN covered less
than 50%, and 4 (5%) of the PICUs handled another
threshold. PN administration via peripheral intravenous
access was possible in 58 of the 81 PICUs (72%).
Regarding the timing of PN initiation, amino acids
would be started within 48 h when a child was (expected
to be) intolerable to EN in 37 of the 81 PICUs (46%).
Initiation of amino acids was postponed beyond the first
week in 4 of the 81 PICUs (5%; Fig. 3). Lipids would be
started within 48 h in 34 of the 81 PICUs (42%; Fig. 3).
Lipids would be initiated beyond the first week in 4 of
the 81 PICUs (5%; Fig. 3). Targeted glucose intake dur-
ing the first 12–24 h varied between 1 and 4mg/kg/min
and 8–10 mg/kg/min. In most cases, 4–6 mg/kg/min
was targeted in children who weighed less than 10 kg
(38 of 81 PICUs, 47%), 1–4 mg/kg/min in children who
weighed 10–30 kg (50 of 81 PICUs, 62%) and also in
children weighing more than 30 kg (62 of 81 PICUs,
77%). Of the 81 respondents, 73 (90%) would administer
vitamins and trace elements routinely.
De-implementation of initiating PN early during critical
illness
Fifty-three of the 81 respondents (65%) answered to be
familiar with the results from the PEPaNIC trial, and 43
(53%) reported to have read the original article. Those
who have read the article were larger PICUs and all
multidisciplinary/mixed, and reported higher propor-
tions of mechanically ventilated patients (Additional file 2:
Table S1). The majority of those who have read the
article would start PN if EN was < 50%, whereas the
majority of those who have not read the article would
start PN if EN was < 80% of target (Additional file 2:
Table S1). Furthermore, those who have read the article
would start amino acids more often within 48 h than
those who did not read the article (Additional file 2:
Table S1).
Of the 43 respondents who have read the article, 9
(21%) interpreted the level of evidence of the PEPaNIC
trial as level 1, 25 (58%) as level 2, and 9 (21%) as level
3. Furthermore, 8 (19%) of these 43 respondents
Table 1 Characteristics of the responding paediatric intensive
care units
Characteristic No. of PICUs (n = 81)
Continent
Europe 39 (48%)
South America 14 (17%)
Asia 12 (15%)
North America 12 (15%)
Africa 2 (3%)
Oceania 2 (3%)
Hospital type
University children’s hospital 37 (46%)
University hospital 24 (30%)
General hospital 18 (21%)
Other 2 (3%)
Type of PICU
Multidisciplinary/mixed 75 (93%)
Medical 4 (5%)
Cardiac 1 (1%)
Surgical 1 (1%)
Combination of PICU
Not combined 66 (82%)
With neonatal ICU 10 (12%)
With adult ICU 4 (5%)
With adult and neonatal ICU 1 (1%)
Size of PICU
1–10 beds 33 (41%)
11–20 beds 28 (35%)
21–30 beds 16 (50%)
> 30 beds 4 (6%)
Paediatric admissions (patients/year)
1–250 7 (9%)
251–500 29 (36%)
501–750 18 (22%)
751–1000 7 (9%)
1001–1250 7 (9%)
> 1250 13 (16%)
Mechanically ventilated patients
< 25% 9 (11%)
25–50% 31 (38%)
50–75% 25 (31%)
> 75% 16 (20%)
PICU paediatric intensive care unit, ICU intensive care unit
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interpreted the grade of recommendation as A (shall be
recommended), 17 (39%) as B (should be recommended),
and 18 (42%) as 0 (can/may be recommended). These 43
respondents all completed the final part of the survey
questions on de-implementation of early PN initiation in
their PICU (Fig. 1). Complete de-implementation of early
PN initiation, due to the results of PEPaNIC, was reported
by 12% (5 of 43) and another 5 (12%) declared to already
withhold PN during the first week prior to PEPaNIC
(Fig. 4). Partial de-implementation was asserted by 17
(40%) of the respondents (Fig. 4). Of these 17 respondents,
16 reported to give PN during the first week only in spe-
cific patient groups (11 to neonates, 11 to undernourished
children, and 4 to other, unspecified patients), and 3
respondents declared to have postponed the timing of
initiation and/or decreasing the amount of amino acids or
lipids. Sixteen (37%) of the 43 PICUs reported no de-
implementation, and continued to administer PN early
during PICU admission. Ten of these PICUs would start
PN within 48 h after admission, of which 6 within 24 h.
Associations between PICU/respondent characteristics
and de-implementation
The degree of de-implementation within the characteris-
tics of the PICUs/respondents is described in Table 2.
Higher proportions of complete de-implementation were
observed in PICUs from which the respondent rated the
level of evidence and grade of recommendation high as
compared with those PICUs who rated them lower
(Additional file 3: Table S2).
Barriers for de-implementation
As familiarity of study results are a condition of studying
de-implementation, we started off with making this dis-
tinction. Of the respondents, only 65% was familiar with
the PEPaNIC study and only 43 (53%) had actually read
the article. Of these 43, 33 respondents reported no or
partial de-implementation and were asked for reasons
not to adopt withholding PN during the first week
(Fig. 1). The most distinct arguments were those that
addressed the safety of postponing PN. The perception
that withholding PN would be harmful to children who
were undernourished on admission (barrier for 17 respon-
dents, 52%) and neonates (barrier for 11 respondents,
33%) were important barriers. Another major concern was
the conviction that parenteral amino acids should be pro-
vided during the acute phase of critical illness (mentioned
by 15 respondents, 46%). Further arguments represented
the need for additional confirmation of the results from
the PEPaNIC trial: waiting for replicating studies (11 re-
spondents; 33%), waiting for updated international guide-
lines (11 respondents; 33%), and waiting for long term
outcome results (8 respondents; 24%) (Table 2). Interest-
ingly, 9 (27%) respondents reported that the results from
the PEPaNIC trial were discussed within their staff but
this had not led to de-implementation of early PN initi-
ation because of lack of consensus (Table 2).
Discussion
This survey showed that nutritional practices continue
to vary greatly among PICUs as was previously reported
Fig. 3 Time to initiate parenteral nutrition when enteral nutrition is (expected to be) insufficient. PICU = paediatric intensive care unit
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[3]. Despite the dearth of evidence in the field of nutri-
tional support in the PICU, in the current survey only
about two-thirds of the respondents asserted to be
familiar with the results from the PEPaNIC trial and
approximately half had read the article. Among these
respondents, PN was completely withheld during the
first week in almost a quarter of the PICUs, and most
PICUs had partially de-implemented early PN initiation,
which meant predominantly that early PN would only be
given to specific patient groups. Reported barriers for
de-implementation were predominantly based on the
conviction that PN during the first week of critical
illness is necessary in neonates and undernourished
children, and especially amino acids were viewed to be
essential.
Although this de-implementation rate might be con-
sidered low, it is to be expected given the relative short
time between publication of PEPaNIC and the survey
(approximately 1 year). It has been shown that it takes
more than a decade from publication to implementation
into practice [13, 14]. An important first step in this
process is to create awareness of new insights [15]. Inter-
estingly, our survey pointed out that even if the existing
evidence in the field is scarce and new results from a
large, international study are published in a high-impact,
open access journal, only two-thirds of the PICUs was
aware of these results.
Besides awareness of new results, (de-)implementation
depends on inhibiting and supporting factors. Previous
studies have identified the following influences: believe
in the benefits for the targeted population, financial im-
plications, organizational structure, caregiver’s motiv-
ation to change current practice, feasibility, quality of
the evidence, credibility of the working group, relevance
and generalizability of the research [16–19]. Indeed,
most of these factors were mentioned in our survey as
arguments not to change current practice. We will
discuss those barriers/facilitators that could guide us to
enhance early de-implementation.
In our survey, 76% still administered PN during the
first week to all critically ill children or specific patient
groups, because they believed in the benefit of early ini-
tiation of PN. Despite the fact that early-PN appeared to
be even more harmful in neonates than in older chil-
dren, and more harmful in children at the highest risk of
malnutrition, as was already reported in the PEPaNIC
article [6], neonates and undernourished children were
predominant barriers. After the survey, additional de-
tailed subgroup analyses of neonates and undernour-
ished children were published, which showed that
Fig. 4 De-implementation of early parenteral nutrition during the first week of paediatric critical illness. PICU = paediatric intensive care unit;
PN = parenteral nutrition
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withholding PN was clinically beneficial in these patients
as well [20, 21]. Concerns on withholding PN in critic-
ally ill children might be explained by several assump-
tions. Since undernourishment on admission has been
associated with worse clinical outcomes, it is assumed
that providing (parenteral) nutrition can improve clinical
outcome by promoting anabolism. In small RCTs, higher
provision of energy and protein/amino acids resulted in
a positive protein balance [22, 23]. Subsequently, it was
assumed that this would also lead to improved clinical
outcome. These assumptions regarding PN might have
reduced the faith in the controversial results from the
PEPaNIC study, which is also reflected in a number of
respondents who requested for repeat studies. Currently,
we could identify one single centre RCT on Clinical-
Trials.gov, which is designed to randomize 80 critically
ill children to receive supplemental PN within 12 or 96 h
after admission [24]. However, for clinicians working in
combined adult/paediatric ICUs, PEPaNIC could have
been considered as a repeat study. Withholding PN for a
week in critically ill adults has been included in the
‘choosing wisely campaign’, a list made by specialty soci-
eties of possible unnecessary healthcare recommenda-
tions [25]. This might explain why PN was completely
withheld in critically ill children during the first week in
all of the combined adult/paediatric ICUs. Additionally,
since evidence for withholding PN during the first week
in critically ill adults has already been published first in
2011 [26], the time between evidence from research and
de-implementation in practice might play a role. Fur-
thermore, a significant proportion of the respondents
mentioned the request for updated guidelines. When the
survey was distributed, the most recent international
guidelines were developed in 2005 and 2009. In the
meantime, these guidelines have been updated by the
leading expert nutrition societies [27, 28], which means
that the time between previous and current versions of
the guidelines was 8 to 13 years. The fact that updated
guidelines were awaited by a significant proportion of re-
spondents stresses the importance of up-to-date guide-
lines. Hence, more frequent updates of the international
guidelines might enhance (de-)implementation.
Despite the factors that hamper de-implementation,
we have observed a shift in the timing of initiation of
PN in critically ill children. In 2013, a worldwide survey
was conducted, addressing nutritional practices in the
PICU [3]. In this survey, the majority (55%) of the
PICUs reported to start PN within 48 h, and 20% within
24 h. Furthermore, PN was completely withheld in only
3.5% of the PICUs before the PEPaNIC results were
published [3]. Comparing these results to the results of
our study, there seems to be a shift towards initiation of
PN between day 2 to 7 and an increase in complete de-
implementation of early PN, although this cannot be
concluded confidently as the responding PICUs were
not exactly the same.
Limiting the delay in de-implementation is of par-
ticular importance in case of harm by an intervention
─ which was the case in early-PN ─ or cost-
ineffectiveness. Based on our results and existing
literature, de-implementation might be accelerated by
increasing awareness, gaining trust on the efficacy
and safety of stopping the intervention, and facilitat-
ing up-to-date international guidelines. An important
aspect to take into account is that the personal will-
ingness and readiness to change a practice differs
widely, which is illustrated by the ‘theory of the diffu-
sion of innovation’ by Rogers et al. [15] According to
this theory, the PICUs who had de-implemented early
PN in our survey could be the ‘Early Adopters’, who
generally have the highest degree of opinion leader-
ship [15]. Hence, the next step to increase awareness
Table 2 Barriers for de-implementation (> 1 answer per PICU
possible) in the 33 PICUs that have partially or not
de-implemented early administration of PN
Barriers No of PICUs
(n = 33)
Safety issues
Not convinced of the safety and/or efficacy in
undernourished children
17
Convinced that critically ill children need amino
acids in the acute phase of illness
15
Not convinced of the safety and/or efficacy in
neonates
11
Convinced that critically ill children need lipids in
the acute phase of illness
6
Not convinced of the safety in general 4
Convinced that critically ill children need more
glucose in the acute phase of illness
2
Confirmation of results
Waiting for updated international guidelinesa 11
Waiting for replicating studies 11
Waiting for long term results 8
Don’t consider these results to be cost-effective 1
Structural reasons
Non-consensus within staff 9
Otherb 5
Lack of nutritional protocol 2
Because of logistic reasons (i.e. arrangements with
pharmacy)
1
Total number of reasons 103
PICU paediatric intensive care unit, PN parenteral nutrition
aRespondents from Europe: n = 7, North America: n = 2, South America: n = 2
and Africa: n = 1
bProvided answers: the PEPaNIC results are not generalizable to our PICU:
n = 3; PN is administrated rarely in our centre: n = 1; we are currently changing
our PN strategies: n = 1
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and gain support, demands the Innovators and Early
Adopters to distribute the knowledge within their net-
works. Furthermore, the concerns on the efficacy and
safety of stopping the intervention (in our case withhold-
ing PN) should be addressed if possible. Since the launch
of this survey, several secondary analyses have investigated
the main concerns, such as the harm associated with ad-
ministration of amino acids [29], the efficacy and safety of
withholding PN in undernourished children [21] and neo-
nates [20], the long-term effects on physical and neuro-
psychological functions [30], and the cost-effectiveness of
withholding PN [31]. All these new findings were support-
ive for de-implementation of early-PN. Additionally,
underlying mechanisms are currently explored [32]. Fi-
nally, since many clinical practices depend on the inter-
national opinion, de-implementation might be accelerated
if the international guidelines would be revised more fre-
quently in order to cover the most up-to-date evidence.
The strength of our study is the widespread responses
from 39 countries. However, some limitations should
also be addressed. First, responses from 81 PICUs are a
small fraction of all PICUs worldwide, which might
decrease generalisability. Possibly, only physicians inter-
ested in nutrition might have responded to our survey,
which poses a risk of selection bias. Second, some an-
swers from the respondents could potentially have been
socially desirable, as this survey has been conducted by
the PEPaNIC study group. Furthermore, some respon-
dents gave inconsistent answers. We have analysed all an-
swers as provided by the respondent to avoid incorrect
interpretation. And third, with this survey, we have mea-
sured theoretical de-implementation based upon the an-
swers of the respondents, without measuring real PN
practices. A previous survey addressing nutritional prac-
tices in PICUs, in which the questionnaire was followed
by a point-prevalence, illustrated that the respondents
often overestimated their practices [3].
Conclusions
One year after the publication of the PEPaNIC trial, only
two-thirds of the respondents was aware of the study re-
sults. Within this group, complete de-implementation of
starting PN in the first week of critical illness was done
in 12% of the PICUs worldwide, and partial de-
implementation was done in 40% of the PICUs. Another
12% of PICUs already withheld PN during the first week.
Important barriers for not de-implementing early PN
were concerns on the efficacy and safety of withholding
PN, and waiting for updated international guidelines.
Increasing the awareness, addressing the intervention-
specific questions and more frequently revising the
international guidelines might help to accelerate de-
implementation of ineffective, unproven or harmful
healthcare.
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